G. Grossi

1.3k total citations
28 papers, 880 citations indexed

About

G. Grossi is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, G. Grossi has authored 28 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 20 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in G. Grossi's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). G. Grossi is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). G. Grossi collaborates with scholars based in Italy, United Kingdom and United States. G. Grossi's co-authors include Pietro Lampertico, Mauro Viganò, Alessandro Loglio, Carlo Ferrari, Carolina Boni, T. Giuberti, Federica Invernizzi, Greta Acerbi, Manuela Ferracin and Luigi Mariani and has published in prestigious journals such as Nature Medicine, Gastroenterology and Scientific Reports.

In The Last Decade

G. Grossi

27 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Grossi Italy 13 561 534 195 122 90 28 880
Vincent Leroy France 17 545 1.0× 636 1.2× 59 0.3× 112 0.9× 87 1.0× 41 945
Shozo Miyake Japan 16 356 0.6× 437 0.8× 56 0.3× 47 0.4× 62 0.7× 38 643
Francesca Saffioti United Kingdom 14 518 0.9× 497 0.9× 114 0.6× 51 0.4× 22 0.2× 43 771
K. H. Wiedmann Germany 13 396 0.7× 348 0.7× 142 0.7× 44 0.4× 26 0.3× 33 815
Juliane Halangk Germany 11 312 0.6× 346 0.6× 157 0.8× 33 0.3× 31 0.3× 20 530
Martine Pernollet France 14 171 0.3× 181 0.3× 358 1.8× 64 0.5× 52 0.6× 33 664
A. Balas Spain 15 223 0.4× 111 0.2× 670 3.4× 131 1.1× 52 0.6× 180 1.1k
A. L. Hepburn United Kingdom 11 127 0.2× 140 0.3× 215 1.1× 52 0.4× 70 0.8× 16 611
Silke Schüle Germany 15 123 0.2× 112 0.2× 103 0.5× 135 1.1× 42 0.5× 43 676
F.B. Bianchi Italy 14 518 0.9× 646 1.2× 54 0.3× 37 0.3× 25 0.3× 33 873

Countries citing papers authored by G. Grossi

Since Specialization
Citations

This map shows the geographic impact of G. Grossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Grossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Grossi more than expected).

Fields of papers citing papers by G. Grossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Grossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Grossi. The network helps show where G. Grossi may publish in the future.

Co-authorship network of co-authors of G. Grossi

This figure shows the co-authorship network connecting the top 25 collaborators of G. Grossi. A scholar is included among the top collaborators of G. Grossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Grossi. G. Grossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loglio, Alessandro, Massimo Iavarone, G. Grossi, et al.. (2018). Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B. Alimentary Pharmacology & Therapeutics. 48(4). 431–439. 5 indexed citations
2.
Boni, Carolina, Andrea Vecchi, Marzia Rossi, et al.. (2018). TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues. Gastroenterology. 154(6). 1764–1777.e7. 112 indexed citations
3.
Loglio, Alessandro, Mauro Viganò, G. Grossi, et al.. (2018). Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and Liver Disease. 51(3). 419–424. 7 indexed citations
4.
Viganò, Mauro, Alessandro Loglio, G. Grossi, & Pietro Lampertico. (2018). Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?. Expert Review of Anti-infective Therapy. 16(2). 153–161. 16 indexed citations
5.
Pinato, David J., Madhava Pai, Isabella Reccia, et al.. (2018). Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma. BMC Cancer. 18(1). 211–211. 12 indexed citations
6.
Galmozzi, E., F. Facchetti, G. Grossi, et al.. (2017). IFNL4 rs368234815 and rs117648444 variants predict off‐treatment HBsAg seroclearance in IFN‐treated HBeAg‐negative chronic hepatitis B patients. Liver International. 38(3). 417–423. 8 indexed citations
7.
Lampertico, Pietro, G. Grossi, Alessandro Loglio, et al.. (2017). High rates of renal tubular damage in HBV monoinfected patients long-term treated with Tenofovir: a cross-sectional, single center, real-life study in 414 patients. Journal of Hepatology. 66(1). S689–S689. 1 indexed citations
8.
Fisicaro, Paola, Valeria Barili, Barbara Montanini, et al.. (2017). Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nature Medicine. 23(3). 327–336. 255 indexed citations
9.
Grossi, G., Alessandro Loglio, F. Facchetti, et al.. (2017). Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance. Journal of Hepatology. 68(1). 195–198. 21 indexed citations
10.
Tosetti, Giulia, Vincenzo La Mura, Alessio Aghemo, et al.. (2017). Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: Beyond the Baveno VI criteria. Digestive and Liver Disease. 49(1). e38–e38. 7 indexed citations
11.
Invernizzi, Federica, Mauro Viganò, G. Grossi, & Pietro Lampertico. (2016). The prognosis and management of inactive HBV carriers. Liver International. 36(S1). 100–104. 56 indexed citations
12.
Viganò, Mauro, et al.. (2016). Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders. Expert Opinion on Biological Therapy. 16(7). 917–926. 25 indexed citations
13.
Viganò, Mauro, Sherrie Bhoori, Pietro Lampertico, et al.. (2015). Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma. Liver International. 35(9). 2187–2193. 2 indexed citations
14.
Smirne, Carlo, G. Grossi, David J. Pinato, et al.. (2015). Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Digestive and Liver Disease. 47(6). 488–494. 34 indexed citations
15.
Viganò, Mauro, G. Grossi, Maria Goldaniga, et al.. (2015). P0655 : Lamivudine prophylaxis prevents hepatitis B reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non-Hodgkin's B cell lymphoma. Journal of Hepatology. 62. S566–S566. 4 indexed citations
16.
Mai, Stefania, Gillian E. Walker, Amelia Brunani, et al.. (2014). Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity. Scientific Reports. 4(1). 5803–5803. 8 indexed citations
17.
Oldani, Alberto, et al.. (2014). A typical behaviour of thymic carcinoma.. PubMed. 85(ePub). 1 indexed citations
18.
Sposito, Carlo, Luigi Mariani, Alessandro Germini, et al.. (2013). Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study. Journal of Hepatology. 59(1). 59–66. 117 indexed citations
19.
Minisini, Rosalba, G. Grossi, Davide Bitetto, et al.. (2011). Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. Journal of Gastroenterology. 46(11). 1307–1315. 6 indexed citations
20.
Grossi, G., et al.. (1969). [On the critical analysis of the moment of the mastocytes in special clinical and experimental ophthalmopathic conditions. II. 11 a. Study of the relation between the degranulation of the mastocyte and the eosinophilic granulocyte in conjunctival biopsies].. PubMed. 35. 167–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026